Cantor Fitzgerald upgraded shares of Root (NASDAQ:ROOT – Free Report) to a strong-buy rating in a research report released on Thursday, Zacks.com reports. Other equities research analysts have also issued research reports about the stock. Keefe, Bruyette & Woods reissued an outperform rating and issued a $82.00 price target (down previously from $88.00) on shares […]

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They presently have a $43.00 target price on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 38.00% from the stock’s current price. A number of other […]

Cantor Fitzgerald upgraded shares of StoneCo (NASDAQ:STNE – Free Report) to a strong-buy rating in a research report released on Thursday, Zacks.com reports. A number of other brokerages also recently commented on STNE. The Goldman Sachs Group reduced their target price on shares of StoneCo from $21.00 to $15.00 and set a buy rating for […]

Cantor Fitzgerald reiterated their overweight rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a research report released on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $155.00 target price on the stock. Cantor Fitzgerald also issued estimates for Merck & Co., Inc.’s FY2024 earnings at $7.66 EPS. A number of […]